homefeedbacksupportlog on 2-Dec-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Infectious Diseases
Antimicrobials & Drug Resistance
Bacterial Infections
Bioterrorism
HIV Infection & AIDS: Basic Science
HIV Infection & AIDS: Clinical
HIV Infection & AIDS: Vaccines
Invasive Fungal Infections
Nosocomial & Healthcare-Associated Infections
Sexually Transmitted Diseases (without HIV)
Tropical & Travel-Associated Diseases
Viral Infections (without HIV)
Related Sections
Gastrointestinal Infections
Gynecologic Inflammation & Infections
Infectious Diseases of the Nervous System
Respiratory Infections
Skin Infections (inc. STDs)
Urological Infections

profile subject selected for My F1000 Medicine

Browse > Infectious Diseases > Invasive Fungal Infections
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals) / Most viewed
(from specialty journals) / Hidden jewels		Page 1 of 5. Select Page: 1 2 3 4 5 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Recommended
F1000 Factor 3.0

Confirmation
 Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism.
Snelders E, van der Lee HA, …, Melchers WJ, Verweij PE
PLoS Med 2008 Nov 11 5(11):e219 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Neil Ampel
Evaluated 28 Nov 2008

Recommended
F1000 Factor 3.0

Hypothesis
 Posaconazole Mono- or Combination Therapy for the Treatment of Murine Zygomycosis.
Ibrahim AS, Gebremariam T, …, Edwards JE, Spellberg B
Antimicrob Agents Chemother 2008 Oct 20 [abstract on PubMed] [related articles] [full text]
Selected by | Fanny Lanternier
Evaluated 26 Nov 2008

Recommended
F1000 Factor 3.0

Tech Advance
 Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay.
Durkin M, Connolly P, …, Pegues D, Wheat LJ
Clin Infect Dis 2008 Oct 15 47(8):e69-73 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Cornelia Lass-Floerl with Astrid Mayr
Evaluated 19 Nov 2008

Must Read
F1000 Factor 6.0
Articles that inform your practice or change your way of thinking Changes
Clinical Practice

Hypothesis
New Finding
 Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.
Bochud PY, Chien JW, …, Aderem A, Boeckh M
N Engl J Med 2008 Oct 23 359(17):1766-77 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Philipp M Lepper
Evaluated 19 Nov 2008

Recommended
F1000 Factor 3.0

Confirmation
 Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
Hamza OJ, Matee MI, …, Verweij PE, van der Ven AJ
Clin Infect Dis 2008 Nov 15 47(10):1270-6 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Ethan Rubinstein with Philippe Lagacé-Wiens
Evaluated 17 Nov 2008

Recommended
F1000 Factor 3.0

New Finding
 Human platelets attenuate Aspergillus species via granule-dependent mechanisms.
Perkhofer S, Kehrel BE, …, von Eiff C, Lass-Flörl C
J Infect Dis 2008 Oct 15 198(8):1243-6 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Emmanuel Roilides with Aspasia Katragkou
Evaluated 23 Oct 2008

Recommended
F1000 Factor 3.0

Confirmation
 Aspergillus fumigatus-induced IL-8 synthesis by respiratory epithelial cells is controlled by the PI3 kinase, p38 MAPK and ERK1/2 pathways and not by the TLR-MYD88 pathway.
Balloy V, Sallenave JM, …, Si-Tahar M, Chignard M
J Biol Chem 2008 Aug 14 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Cornelia Lass-Floerl with Susanne Perkhofer
Evaluated 2 Oct 2008

Recommended
F1000 Factor 3.2

Confirmation
 SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia.
Charles PG, Wolfe R, …, Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML
Clin Infect Dis 2008 Aug 1 47(3):375-84 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Mark Metersky with Jafar Abunasser / Ric Price with Krispin Hajkowicz
First evaluation 29 Sep 2008 | Latest evaluation 9 Oct 2008

Recommended
F1000 Factor 3.0

New Finding
 Therapeutic Effect of a Novel Oxazolidinone, DA-7867, in BALB/c Mice Infected with Nocardia brasiliensis
Vera-Cabrera L, Daw-Garza A, …, Choi S-H, Welsh O
PLoS Neglected Tropical Diseases 2008 2 [FREE full text]
Selected by | M Ramam
Evaluated 11 Sep 2008

Must Read
F1000 Factor 4.8

Confirmation
 Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Segal BH, Herbrecht R, …, Dismukes WE, De Pauw BE
Clin Infect Dis 2008 Sep 1 47(5):674-83 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Randall Hayden with Gabriela Maron / Francoise Dromer with Caroline Charlier
First evaluation 10 Sep 2008 | Latest evaluation 27 Oct 2008


top of pagePage 1 of 5. Select Page: 1 2 3 4 5 >>
Display 10 / 20 / 50 papers per page

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info